<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR32">
 <label>32.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Keilholz</surname>
    <given-names>U</given-names>
   </name>
   <name>
    <surname>Letsch</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Busse</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS</article-title>
  <source>Blood</source>
  <year>2009</year>
  <volume>113</volume>
  <fpage>6541</fpage>
  <lpage>6548</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2009-02-202598</pub-id>
  <?supplied-pmid 19389880?>
  <pub-id pub-id-type="pmid">19389880</pub-id>
 </element-citation>
</ref>
